Cancer Diagnostics Market Size, Share & Growth Report | 2031

Segments - Cancer Diagnostics Market by Types (Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy, Barium Enema, and Others), Applications (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

Cancer Diagnostics Market Outlook 2031

The global cancer diagnostics market size was valued at USD 19.18 Billion in 2022 and is likely reach to USD 51.09 Billion by 2031, expanding at a CAGR of 11.5% during the forecast period, 2023 – 2031. The growth of the market is attributed to the increasing occurrences of oncologic cases, growing need of effective screen testing, and continuous technological developments in the study and development of cancer.

Cancer is defined as a collection of diseases that involve abnormal cell growth, which has the ability to spread at a rapid pace and can also invade towards additional components of the body. Initial symptoms and signs include prolonged cough, a lump, and irregularities in bowel movements, unexplained weight loss, and abnormal bleeding.

The use of tobacco is considered to be the main cause of cancer deaths. Other reasons can be due to obesity, lack of physical activity, sedentary lifestyle, excess drinking habit of alcohol, and poor diet. Experience to ionizing radiation, environmental pollutants, and certain infections can also attribute to cancer formation.

The risk involved in the development of most cancers can be controlled by following a healthy lifestyle, maintaining a good body mass index, quit smoking, limiting alcohol intake, vaccination against infectious diseases, and eating nutritious fruits, whole grains and vegetables. Researchers, doctors, and scientists have discovered different approaches to the treatment of cancer, which varies upon the stages which the patient is undergoing.

Physical examinations are the preliminary methods where the doctors seek to find information for any abnormalities in the patient such as enlargement of certain organs and changing in skin color. Laboratory testing such as blood and urine tests are widely adopted by doctors to identify deformities that can lead to cancer.

Imaging tests allow the doctor to investigate the patient’s internal organs and bones as well as search for signs leading to cancer effectively and accurately. Moreover, doctors can also collect samples of cells for the biopsy testing, which depends on the organ to which the cancer is diagnosed towards.

The COVID-19 pandemic has reduced the growth of the global cancer diagnostics product & services market initially. However, upon further studies, researchers and scientists found out that the coronavirus has the viral gene of accelerating illness of the hosts. Basically, a patient of cancer was more susceptible to the COVID-19 virus than that of a healthy person.

This steered to hospitals, clinics, and healthcare laboratories to focus more on both COVID-19 vaccination and cancer diagnosis simultaneously for the prevention and treatment of diseases and this led to its market growth.

Cancer Diagnostics Market Trends, Drivers, Restraints, and Opportunities

The major driver for the global cancer diagnostics market is the rising awareness of different cancer diagnostic procedures along with favorable government initiatives for the treatment and diagnosis of this disease.
The increase in funding and investments from both the government and private investors to the diagnosis to cancer present a major driver for the growth in this market.
Numerous screening practices such as imaging, endoscopy, and other laboratory tests, which enable the detection of disease at the preliminary stage. This is projected to boost the market growth.
Several risk factors related to the using of medical imaging acts as a key challenge that can hinder towards the global cancer diagnostics market growth.
High cost in performing of the cancer diagnosis especially in developing countries is a major restraint in the global cancer diagnostics market.

Scope of Cancer Diagnostics Market Report

The report on the global cancer diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Cancer Diagnostics Market Size - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2022
Historic Data	2016–2021
Forecast Period	2023–2031
Segmentation	Types (Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy, Barium Enema, and Others) and Applications (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, and Others)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast
Key Players Covered in the Report	GE Healthcare; Abbott Laboratories; F.Hoffmann-La Roche Ltd; Siemens Healthcare GmbH; Becton, Dickinson & Company; Illumina Inc.; Koninklijke Philips N.V; and Hologic Inc.

Cancer Diagnostics Market Segment Insights

Imaging segment to lead the market share

Based on types, the global cancer diagnostics market is segmented into laboratory tests, genetic tests, imaging, endoscopy, biopsy, barium enema, and others. The imaging segment is expected to lead the market in terms of the revenue share in the coming years owing to wide adoption of imagining process for cancer detection.

Latest imaging sensory systems such as the magnetic resonance imaging and the computer tomography scanning are pain-free diagnostic, precise, accurate, non-invasive, and quick solutions.

These imaging modalities can also be used for supportive testing as well as other genetic and laboratory tests to understand the severity and location of the cancer condition that is dwelled in the patient’s body. These factors are also the main reason to boost the imaging segment during the forecast period.

On the other hand, the laboratory and genetic tests segments in combined is projected to register a significant CAGR during the forecast period. During the process of cancer diagnosis of a patient, the genetic and laboratory tests are done on the preliminary basis and then the imaging test procedure is conducted for conclusive diagnosis of the cancer.

Breast Cancer to constitute a large market share

On the basis of applications, the market is divided into breast cancer, colorectal cancer, cervical cancer, lung cancer, prostate cancer, skin cancer, blood cancer, kidney cancer, pancreatic cancer, ovarian cancer, and others. The breast cancer segment is anticipated to constitute a large market share in the coming years owing to the rise of wide application of mammography. It is considered to be one of the most popular and common screening tests for breast tumor and cancer screening

Cancer Diagnostics Market Regional Outlook

North America to hold a major revenue market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a dominant market share representing more than 40% of the global market share in 2016 and is expected to continue this trend during the forecast period, 2023-2031.

The presence of major key players in the region and existing favorable healthcare insurance to its citizens. Along the greater funding available for research and development activities, the adoption of advanced technology in cancer diagnostics devices and kits is a key factor propelling the regional market growth.

Meanwhile, the market in Asia Pacific is anticipated to register a substantial CAGR during the forecast period owing to rising number of cancer patients and growing awareness of cancer diagnostic process. Several government policies to improve the existing healthcare facilities and expansion of various medical infrastructure in the region play another key factor for the market growth in Asia Pacific.

Segments

Types

Laboratory Tests
Genetic Tests
Imaging
Endoscopy
Biopsy
Barium Enema
Others

Applications

Breast Cancer
Colorectal Cancer
Cervical Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Blood Cancer
Kidney Cancer
Pancreatic Cancer
Ovarian Cancer
Others

Regions

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

GE Healthcare
Abbott Laboratories
F.Hoffmann-La Roche Ltd
Siemens Healthcare GmbH
Becton, Dickinson & Company
Illumina Inc.
Koninklijke Philips N.V
Hologic Inc.

Competitive Landscape

Some of the major players competing in the global cancer diagnostics market are GE Healthcare; Abbott Laboratories; F.Hoffmann-La Roche Ltd; Siemens Healthcare GmbH; Becton, Dickinson & Company; Illumina Inc.; Koninklijke Philips N.V; and Hologic Inc.

These players are currently focused on research and development activities to provide innovative technique and kits for cancer diagnostics to ensure that these innovative methods are for low cost and time efficiency.

Cancer Diagnostics Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cancer Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Cancer Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Cancer Diagnostics Market - Supply Chain
  4.5. Global Cancer Diagnostics Market Forecast
     4.5.1. Cancer Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Cancer Diagnostics Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Cancer Diagnostics Market Absolute $ Opportunity
5. Global Cancer Diagnostics Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Cancer Diagnostics Market Size and Volume Forecast by Types
     5.3.1. Laboratory Tests
     5.3.2. Genetic Tests
     5.3.3. Imaging
     5.3.4. Endoscopy
     5.3.5. Biopsy
     5.3.6. Barium Enema
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Cancer Diagnostics Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Cancer Diagnostics Market Size and Volume Forecast by Applications
     6.3.1. Breast Cancer
     6.3.2. Colorectal Cancer
     6.3.3. Cervical Cancer
     6.3.4. Lung Cancer
     6.3.5. Prostate Cancer
     6.3.6. Skin Cancer
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Cancer Diagnostics Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Cancer Diagnostics Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Cancer Diagnostics Demand Share Forecast, 2019-2026
8. North America Cancer Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Cancer Diagnostics Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Cancer Diagnostics Market Size and Volume Forecast by Types
     8.4.1. Laboratory Tests
     8.4.2. Genetic Tests
     8.4.3. Imaging
     8.4.4. Endoscopy
     8.4.5. Biopsy
     8.4.6. Barium Enema
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Cancer Diagnostics Market Size and Volume Forecast by Applications
     8.7.1. Breast Cancer
     8.7.2. Colorectal Cancer
     8.7.3. Cervical Cancer
     8.7.4. Lung Cancer
     8.7.5. Prostate Cancer
     8.7.6. Skin Cancer
  8.8. Basis Point Share (BPS) Analysis by Applications
  8.9. Y-o-Y Growth Projections by Applications
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Cancer Diagnostics Demand Share Forecast, 2019-2026
9. Latin America Cancer Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Cancer Diagnostics Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Cancer Diagnostics Market Size and Volume Forecast by Types
     9.4.1. Laboratory Tests
     9.4.2. Genetic Tests
     9.4.3. Imaging
     9.4.4. Endoscopy
     9.4.5. Biopsy
     9.4.6. Barium Enema
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Cancer Diagnostics Market Size and Volume Forecast by Applications
     9.7.1. Breast Cancer
     9.7.2. Colorectal Cancer
     9.7.3. Cervical Cancer
     9.7.4. Lung Cancer
     9.7.5. Prostate Cancer
     9.7.6. Skin Cancer
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Cancer Diagnostics Demand Share Forecast, 2019-2026
10. Europe Cancer Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Cancer Diagnostics Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Cancer Diagnostics Market Size and Volume Forecast by Types
     10.4.1. Laboratory Tests
     10.4.2. Genetic Tests
     10.4.3. Imaging
     10.4.4. Endoscopy
     10.4.5. Biopsy
     10.4.6. Barium Enema
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Cancer Diagnostics Market Size and Volume Forecast by Applications
     10.7.1. Breast Cancer
     10.7.2. Colorectal Cancer
     10.7.3. Cervical Cancer
     10.7.4. Lung Cancer
     10.7.5. Prostate Cancer
     10.7.6. Skin Cancer
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Cancer Diagnostics Demand Share Forecast, 2019-2026
11. Asia Pacific Cancer Diagnostics Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Cancer Diagnostics Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Cancer Diagnostics Market Size and Volume Forecast by Types
     11.4.1. Laboratory Tests
     11.4.2. Genetic Tests
     11.4.3. Imaging
     11.4.4. Endoscopy
     11.4.5. Biopsy
     11.4.6. Barium Enema
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Cancer Diagnostics Market Size and Volume Forecast by Applications
     11.7.1. Breast Cancer
     11.7.2. Colorectal Cancer
     11.7.3. Cervical Cancer
     11.7.4. Lung Cancer
     11.7.5. Prostate Cancer
     11.7.6. Skin Cancer
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Cancer Diagnostics Demand Share Forecast, 2019-2026
12. Middle East & Africa Cancer Diagnostics Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Cancer Diagnostics Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Cancer Diagnostics Market Size and Volume Forecast by Types
     12.4.1. Laboratory Tests
     12.4.2. Genetic Tests
     12.4.3. Imaging
     12.4.4. Endoscopy
     12.4.5. Biopsy
     12.4.6. Barium Enema
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Cancer Diagnostics Market Size and Volume Forecast by Applications
     12.7.1. Breast Cancer
     12.7.2. Colorectal Cancer
     12.7.3. Cervical Cancer
     12.7.4. Lung Cancer
     12.7.5. Prostate Cancer
     12.7.6. Skin Cancer
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Cancer Diagnostics Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Cancer Diagnostics Market: Market Share Analysis
  13.2. Cancer Diagnostics Distributors and Customers
  13.3. Cancer Diagnostics Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. GE Healthcare
     13.4.2. Abbott Laboratories
     13.4.3. F.Hoffmann-La Roche Ltd
     13.4.4. Siemens Healthcare GmbH
     13.4.5. Becton, Dickinson & Company
     13.4.6. Illumina Inc.